Estimated Revenue: $50M to $100M
Investor Type: For Profit
Investors Number: 11
Industry: PharmTech
Funding Status: IPO
Technology: Anti-infective Drugs
Employee Number: 51-100
Headquarters: San Diego, California, United States
Last Funding Type: Post-IPO Equity
Total Funding: $720.7M
Founded Date: 2013